Quest Diagnostics
DGX
#1092
Rank
ยฃ15.34 B
Marketcap
ยฃ137.21
Share price
-0.68%
Change (1 day)
10.32%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total assets

Total assets on the balance sheet as of September 2025 : ยฃ12.14 Billion

According to Quest Diagnostics 's latest financial reports the company's total assets are ยฃ12.14 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Quest Diagnostics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ12.87 B16.95%
2023-12-31ยฃ11.00 B3.73%
2022-12-31ยฃ10.61 B5.23%
2021-12-31ยฃ10.08 B-2.01%
2020-12-31ยฃ10.29 B5.06%
2019-12-31ยฃ9.79 B12.99%
2018-12-31ยฃ8.66 B11.54%
2017-12-31ยฃ7.77 B-5.06%
2016-12-31ยฃ8.18 B21.76%
2015-12-31ยฃ6.72 B6.18%
2014-12-31ยฃ6.33 B16.71%
2013-12-31ยฃ5.42 B-5.56%
2012-12-31ยฃ5.74 B-4.14%
2011-12-31ยฃ5.99 B8.47%
2010-12-31ยฃ5.52 B4.38%
2009-12-31ยฃ5.29 B-7.71%
2008-12-31ยฃ5.73 B32.99%
2007-12-31ยฃ4.31 B49.18%
2006-12-31ยฃ2.89 B-6.07%
2005-12-31ยฃ3.07 B40.52%
2004-12-31ยฃ2.18 B-8.94%
2003-12-31ยฃ2.40 B15.98%
2002-12-31ยฃ2.07 B2.57%
2001-12-31ยฃ2.02 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
LabCorp
LH
ยฃ13.69 B 12.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
ยฃ6.23 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
ยฃ1.03 B-91.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
ยฃ47.64 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
ยฃ4.91 B-59.54%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands